Active Ingredient(s):Istradefylline FDA Approved: * August 27, 2019 Pharm Company: *KYOWA KIRIN Category:Parkinsons
Istradefylline, sold under the brand name Nourianz, is a medication used as an add-on treatment to levodopa/carbidopa in adults with Parkinson's disease (PD) experiencing "off" episodes. Istradefylline reduces "off" periods resulting from long-term treatment with the antiparkinson drug levodopa. An "off" episode is a time when a patient's medications are not working well, causing an increase in PD symptoms, such as tr...
* May have multiple approval dates, manufacturers, or labelers.